×
戻る Agenda
S28 : The Ideal State of Clinical Trials in Japan and the Creation of a Clinical Trial Ecosystem through the Implementation of DCT in the Oncology Field
Session Chair(s)
Takuma Matsunaga
Business Producer, DCT Unit, MICIN, Inc., Japan
Mami Takahashi
Clinical IT Solution Architect, Clinical System and Informatics Group, , Chugai Pharmaceutical Co., Ltd., Japan
Speaker(s)
Takafumi Koyama
Head of Physicians, Department of Experimental Therapeutics, National Cancer Center Hospital, Japan
Hiroya Taniguchi, MD
Head Physician, Department of Clinical Oncology, Aichi Cancer Center Hospital, Japan
Kanako Saito
Associate Director, Clinical Lead, Clinical Development, Eli Lilly Japan K.K., Japan
Yuji Minami
Associate Director,Development Operations Excellence, Takeda Pharmaceutical Company Limited, Japan
Tomokazu Handa
Trial Lead Department, Manager, Janssen Pharmaceutical K.K., Japan